NorthernLight Diagnostics AB

NorthernLight Diagnostics AB manufactures the Ahead, a treatment advisor designed to assist healthcare providers in clinical decision-making. This device integrates diagnostic data to offer personalized treatment recommendations, helping optimize patient care pathways. The company’s portfolio focuses on tools that support evidence-based therapeutic strategies.

NorthernLight Diagnostics AB is headquartered in Sweden. The company’s location in Sweden aligns with the EU’s regulatory framework, which governs its medical device portfolio.

NorthernLight Diagnostics AB’s devices are listed in the EUDAMED database, which is the European Union’s central registry for medical device information. This inclusion ensures transparency and compliance with EU regulatory requirements for Class IIa devices.

NorthernLight Diagnostics AB’s devices fall under EU Class IIa, the second-lowest risk category for medical devices. This classification is determined by factors such as the device’s intended purpose (e.g., assisting in treatment decisions) and its potential impact on patient safety, requiring compliance with specific EU directives and conformity assessment procedures.